Morepen Laboratories Shares

Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June quarter of the financial year 2021-22, while its share price gained around 3 per cent

Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.

The board of Morepen Laboratories has made an allotment of 9,24,90,413 equity shares of Rs 2 each to the fixed deposit holders of the company. These shares have been allotted at a price of Rs 11.32 per share pursuant to the order dated 04 August 2009 of the Hon'ble High Court of Himachal Pradesh at Shimla approving the scheme of compromise and arra...

The board meeting of Morepen Laboratories will be held 12 August 2009 to make the allotment of equity shares of Rs 2 each, pursuant to a scheme of compromise or arrangement approved on 04 August 2009 by the Hon'ble High Court of Himachal Pradesh to the fixed deposit holders of the company.

Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June quarter of the financial year 2021-22, while its share price gained around 3 per cent

Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.

The board of Morepen Laboratories has made an allotment of 9,24,90,413 equity shares of Rs 2 each to the fixed deposit holders of the company. These shares have been allotted at a price of Rs 11.32 per share pursuant to the order dated 04 August 2009 of the Hon'ble High Court of Himachal Pradesh at Shimla approving the scheme of compromise and arra...

The board meeting of Morepen Laboratories will be held 12 August 2009 to make the allotment of equity shares of Rs 2 each, pursuant to a scheme of compromise or arrangement approved on 04 August 2009 by the Hon'ble High Court of Himachal Pradesh to the fixed deposit holders of the company.